The remainder of the cases are of a germinal center B-cell (GCB) subtype, which is defined by CD10 expression in at least 30% of tumor cells or Bcl-6 expression in the absence of MUM1 expression [33]. The gene discussed is BCL6; the disease is neoplasm.